Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.8148
-0.0238 (-2.84%)
Mar 31, 2025, 12:41 PM EDT - Market open
Coherus BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 125.99 | 102.89 | 63.55 | 417.2 | 541.16 | Upgrade
|
| Short-Term Investments | - | 14.86 | 128.13 | - | - | Upgrade
|
| Cash & Short-Term Investments | 125.99 | 117.75 | 191.68 | 417.2 | 541.16 | Upgrade
|
| Cash Growth | 7.00% | -38.57% | -54.05% | -22.91% | 204.59% | Upgrade
|
| Accounts Receivable | 111.32 | 260.52 | 109.96 | 123.02 | 157.05 | Upgrade
|
| Other Receivables | 11.01 | - | - | - | - | Upgrade
|
| Receivables | 122.33 | 260.52 | 109.96 | 123.02 | 157.05 | Upgrade
|
| Inventory | 70.09 | 62.61 | 38.79 | 37.64 | 44.23 | Upgrade
|
| Prepaid Expenses | 23.17 | 34.76 | 40.8 | 24.46 | 25.04 | Upgrade
|
| Total Current Assets | 341.58 | 475.63 | 381.23 | 602.32 | 767.48 | Upgrade
|
| Property, Plant & Equipment | 7.36 | 11.03 | 14.44 | 16.01 | 10.11 | Upgrade
|
| Goodwill | - | 0.94 | 0.94 | 0.9 | 0.94 | Upgrade
|
| Other Intangible Assets | 53.65 | 70.73 | 4.99 | 2.66 | 2.62 | Upgrade
|
| Other Long-Term Assets | 45.95 | 71.27 | 79.24 | 57.44 | 60.5 | Upgrade
|
| Total Assets | 448.53 | 629.6 | 480.85 | 679.33 | 841.65 | Upgrade
|
| Accounts Payable | 28.46 | 35.22 | 11.53 | 16.16 | 15.2 | Upgrade
|
| Accrued Expenses | 227.04 | 291.11 | 122.85 | 145.68 | 127.32 | Upgrade
|
| Current Portion of Long-Term Debt | 1.15 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.69 | 2.15 | 4.32 | 3.49 | 3.13 | Upgrade
|
| Other Current Liabilities | 24.65 | 3.3 | - | - | - | Upgrade
|
| Total Current Liabilities | 282.98 | 331.77 | 138.69 | 165.33 | 145.65 | Upgrade
|
| Long-Term Debt | 292.52 | 473.37 | 471.06 | 408.28 | 404.02 | Upgrade
|
| Long-Term Leases | 3.29 | 5.33 | 5.05 | 7.25 | 9.95 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.1 | 1.1 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.63 | 11.46 | 3.47 | 0.75 | 1.05 | Upgrade
|
| Total Liabilities | 580.52 | 823.03 | 618.27 | 581.61 | 560.68 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,419 | 1,386 | 1,204 | 1,148 | 1,044 | Upgrade
|
| Retained Earnings | -1,551 | -1,580 | -1,342 | -1,050 | -762.75 | Upgrade
|
| Comprehensive Income & Other | -0.28 | -0.25 | -0.25 | -0.27 | -0.27 | Upgrade
|
| Total Common Equity | -131.99 | -193.43 | -137.42 | 97.73 | 280.97 | Upgrade
|
| Shareholders' Equity | -131.99 | -193.43 | -137.42 | 97.73 | 280.97 | Upgrade
|
| Total Liabilities & Equity | 448.53 | 629.6 | 480.85 | 679.33 | 841.65 | Upgrade
|
| Total Debt | 298.65 | 480.84 | 480.42 | 419.02 | 417.1 | Upgrade
|
| Net Cash (Debt) | -172.66 | -363.09 | -288.74 | -1.83 | 124.06 | Upgrade
|
| Net Cash Per Share | -1.50 | -3.86 | -3.72 | -0.02 | 1.49 | Upgrade
|
| Filing Date Shares Outstanding | 115.9 | 112.71 | 79.61 | 77.28 | 72.79 | Upgrade
|
| Total Common Shares Outstanding | 115.61 | 112.22 | 78.85 | 76.93 | 72.51 | Upgrade
|
| Working Capital | 58.6 | 143.86 | 242.54 | 437 | 621.83 | Upgrade
|
| Book Value Per Share | -1.14 | -1.72 | -1.74 | 1.27 | 3.87 | Upgrade
|
| Tangible Book Value | -185.64 | -265.1 | -143.35 | 94.16 | 277.41 | Upgrade
|
| Tangible Book Value Per Share | -1.61 | -2.36 | -1.82 | 1.22 | 3.83 | Upgrade
|
| Machinery | 18.07 | 17.73 | 17.39 | 16.04 | 18.57 | Upgrade
|
| Construction In Progress | - | - | 0.7 | 0.39 | 0.31 | Upgrade
|
| Leasehold Improvements | 5.75 | 5.75 | 6.2 | 5.94 | 5.83 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.